EMPLOYMENT AGREEMENT -------------------- THIS EMPLOYMENT AGREEMENT (this "Agreement") is dated as of the 4th day of October, 2001, and is by and between Senesco, Inc., a New Jersey corporation with an office for purposes of this Agreement at 303...Employment Agreement • February 14th, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • New Jersey
AGREEMENT ---------Registration Rights Agreement • February 14th, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
COMMON STOCK PURCHASE WARRANT Eloxx Pharmaceuticals, Inc.Common Stock Purchase Warrant • November 13th, 2023 • Eloxx Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Armistice Capital Master Fund Ltd. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on March 19, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Eloxx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to 380,590 shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 12th, 2013 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December ____, 2013, between Senesco Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 29th, 2010 • Senesco Technologies Inc • Services-commercial physical & biological research
This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 26, 2010, between Senesco Technologies Inc., a Delaware corporation (the “Company”), and each of the purchasers who are signatories hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
1. Payments. Subject to Section 2 hereof, all principal and interest due -------- hereunder shall be payable in one (1) installment on October 22, 1999 (the "Maturity Date"); provided, however, that the parties may -------- ------- mutually agree to...Loan Agreement • May 24th, 1999 • Nava Leisure Usa Inc • Blank checks • New Jersey
Warrant No. Number of Shares: ----- --------- (subject to adjustment) Date of Issuance: , 2004 ------------ Original Issue Date (as defined in subsection 2(a)): , 2004 -------------Common Stock Purchase Warrant • February 3rd, 2004 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
SENESCO TECHNOLOGIES, INC. INDEMNIFICATION AGREEMENT This Indemnification Agreement ("Agreement") is made as of October 4, 2001 by and between Senesco Technologies, Inc., a Delaware corporation (the "Company"), and Bruce C. Galton ("Indemnitee")....Indemnification Agreement • February 14th, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • New Jersey
COMMON STOCK PURCHASE WARRANT SENESCo TECHNOLOGIES, INC.Security Agreement • January 4th, 2013 • Senesco Technologies Inc • Services-commercial physical & biological research
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after January __, 2013 (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Issuance Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Senesco Technologies, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is one of a series of warrants issued by the Company in connection with a public offering of Common Stock and of like tenor, except as to the number of shares of Common Stock subject thereto (coll
WARRANT -------Warrant Agreement • January 2nd, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
AMENDMENT NO. 1 TO REGISTRATION RIGHTS AGREEMENT This AMENDMENT NO. 1 TO REGISTRATION RIGHTS AGREEMENT (the "Amendment") is dated as of February 12, 2004, by and among Senesco Technologies, Inc., a Delaware corporation (the "Company"), and those...Registration Rights Agreement • February 13th, 2004 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 6th, 2013 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December ____, 2013, between Senesco Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECTION ICommon Stock Purchase Agreement • September 28th, 2000 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
AGREEMENT ---------Registration Rights Agreement • September 28th, 2000 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT This AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT (this "Amendment"), dated as of February 12, 2004, by and among Senesco Technologies, Inc., a Delaware corporation (the "Company"), and those...Securities Purchase Agreement • February 13th, 2004 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
SECTION ISecurities Purchase Agreement • February 14th, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
SECTION ISecurities Purchase Agreement • February 14th, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
ELOXX PHARMACEUTICALS, INC. Shares of Common Stock ($0.01 par value per share) SALES AGREEMENTSales Agreement • May 24th, 2023 • Eloxx Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Eloxx Pharmaceuticals, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc. (the “Agent”), as follows:
AGREEMENT ---------Registration Rights Agreement • January 2nd, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
1.1 THE LOAN. Subject to the terms of this Agreement, the Company shall borrow from the Lender and the Lender shall lend to the Company up to Two Hundred Two Thousand Dollars ($202,000) (the "Loan") pursuant to a promissory note in the form attached...Loan Agreement • May 24th, 1999 • Nava Leisure Usa Inc • Blank checks • New Jersey
ELOXX PHARMACEUTICALS, INC. AND [•], AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF [•], 20[•] ELOXX PHARMACEUTICALS, INC. FORM OF PREFERRED STOCK WARRANT AGREEMENTPreferred Stock Warrant Agreement • November 16th, 2018 • Eloxx Pharmaceuticals, Inc. • Services-commercial physical & biological research • New York
THIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between ELOXX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
AGREEMENT ---------Registration Rights Agreement • September 28th, 2000 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
PLACEMENT AGENT AGREEMENTPlacement Agent Agreement • September 28th, 2000 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
BETWEENLease Agreement • May 15th, 2001 • Senesco Technologies Inc • Services-commercial physical & biological research
ELOXX PHARMACEUTICALS, INC. AND [•], AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF [•], 20[•] ELOXX PHARMACEUTICALS, INC. FORM OF COMMON STOCK WARRANT AGREEMENTCommon Stock Warrant Agreement • November 16th, 2018 • Eloxx Pharmaceuticals, Inc. • Services-commercial physical & biological research • New York
THIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between ELOXX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 9th, 2013 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of May 9, 2013, between Senesco Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
ELOXX PHARMACEUTICALS, INC. and [•], AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [•], 20[•] ELOXX PHARMACEUTICALS, INC. FORM OF DEBT SECURITIES WARRANT AGREEMENTWarrant Agreement • November 16th, 2018 • Eloxx Pharmaceuticals, Inc. • Services-commercial physical & biological research • New York
This DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between ELOXX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
SERIES FB COMMON STOCK PURCHASE WARRANT Senesco Technologies, Inc.Common Stock Purchase Warrant • May 19th, 2014 • Senesco Technologies Inc • Services-commercial physical & biological research
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [ ] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after May 16, 2014 (the “Initial Exercise Date”) and on or prior to the close of business on June 16, 2014 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Senesco Technologies, Inc., a Delaware corporation (the “Company”), up to [ ] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
EMPLOYMENT AGREEMENT -------------------- THIS EMPLOYMENT AGREEMENT (this "Agreement") is dated as of the 1st day of July, 2003, and is by and between Senesco, Inc., a New Jersey corporation with an office for purposes of this Agreement at 303 George...Employment Agreement • September 29th, 2003 • Senesco Technologies Inc • Services-commercial physical & biological research • New Jersey
THE SECURITY REPRESENTED BY THIS CERTIFICATE HAS BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISPOSITION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT...Nonstatutory Stock Option Agreement • November 15th, 1999 • Senesco Technologies Inc • Blank checks
SECTION ISecurities Purchase Agreement • January 2nd, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
Exhibit 10.2 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. Collaboration AgreementCollaboration Agreement • November 14th, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • New Jersey
September 12, 2003 Senesco Technologies, Inc. 303 George Street, Suite 420 New Brunswick, NJ 08901 Attention: Bruce C. Galton, President & CEO Financial Advisory Agreement ---------------------------- Dear Mr. Galton: This is to confirm our...Financial Advisory Agreement • November 14th, 2003 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
PRE-FUNDED COMMON STOCK PURCHASE WARRANT Eloxx Pharmaceuticals, Inc.Security Agreement • January 25th, 2024 • Eloxx Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, SD MF 4 LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”), to subscribe for and purchase from Eloxx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to 471,508 shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 13th, 2023 • Eloxx Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September 18, 2023, between Eloxx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
